Loss of the tumor suppressor, Tp53, enhances the androgen receptor-mediated oncogenic transformation and tumor development in the mouse prostate
Yongfeng He(Cornell University), Zijie Sun(Stanford University), Joseph Aldahl(City of Hope), Sungyong You(Cedars-Sinai Medical Center), Robert D. Cardiff(University of California, Davis), Erika Hooker(Hôpital Maisonneuve-Rosemont), Won Kyung Kim(City of Hope), Donghoon Lee(City of Hope), Junhee Yoon(Cedars-Sinai Medical Center), Eun‐Jeong Yu(National Institutes of Health), Julie Yang(City of Hope), Vien Le(City of Hope), Joseph Geradts(East Carolina University), Huiqing Wu(City Of Hope National Medical Center), D. T. Johnson(Memorial Hermann)
Cited by 9
Related Papers
Linking β-Catenin to Androgen-signaling Pathway
|Journal of Biological Chemistry|2002|340
Phosphatidylinositol 3-Kinase/Akt Stimulates Androgen Pathway through GSK3β Inhibition and Nuclear β-Catenin Accumulation
|Journal of Biological Chemistry|2002|303
Protein kinase CK2 in mammary gland tumorigenesis
|Oncogene|2001|296
Activation of Akt (Protein Kinase B) in Mammary Epithelium Provides a Critical Cell Survival Signal Required for Tumor Progression
|Molecular and Cellular Biology|2001|279